Not applicableWithdrawnNCT02594943What this trial is testingEndodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric CancerWho this might be right forStomach Neoplasms Region Skane
Not applicableStudy completedNCT01939275What this trial is testing64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+10 more City of Hope Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT00061932What this trial is testingBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Ended earlyNCT05500508What this trial is testingOral AMXT 1501 Dicaprate in Combination With IV DFMOWho this might be right forCancerSolid TumorSolid Carcinoma+17 more Aminex Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Testing effectiveness (Phase 2)Study completedNCT00084604What this trial is testingIrinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)UnknownNCT00637637What this trial is testingExternal-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesWho this might be right forCancer Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Study completedNCT01212822What this trial is testingBevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+17 more Fox Chase Cancer Center 20
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT03894618What this trial is testingSL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasWho this might be right forSquamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more Shattuck Labs, Inc. 49
Testing effectiveness (Phase 2)WithdrawnNCT02344810What this trial is testingC-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT01643499What this trial is testingGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesWho this might be right forAcinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more University of Chicago 79
Testing effectiveness (Phase 2)Study completedNCT01260701What this trial is testingAkt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Gastric AdenocarcinomaGastric Intestinal Type Adenocarcinoma+2 more National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT04772989What this trial is testingEvaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more Arcus Biosciences, Inc. 94
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT00103324What this trial is testingS0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach CancerWho this might be right forDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the StomachMixed Adenocarcinoma of the Stomach+3 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT01612546What this trial is testingPilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by SurgeryWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT03365791What this trial is testingPDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesWho this might be right forSmall Cell Lung CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+5 more Novartis Pharmaceuticals 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07315035What this trial is testingQL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric CancerWho this might be right forGastric Cancer Stage III The First Affiliated Hospital with Nanjing Medical University 74
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals